Dermatology Times, January 2022 (Vol. 43. No. 1)

In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, an adjunct assistant professor of dermatology at Duke University School of Medicine in Durham, North Carolina, and chief medical editor of Dermatology Times®, tackles cosmetic box claims and what exactly 'sensitive skin' means in the cosmetic world.

The new year promises to be rich with dermatology game changers following a sluggish 2021 for breakthroughs and FDA approvals.

Skin cancer dermoscopy is getting a hightech overhaul as the scope of innovation broadens from a singular focus on the stand-alone product to the development of a comprehensive medical, patient care, and workflow management platform.

Skin sensitivity will be a factor in vehicles for new treatments.

Dermatology Times® broke the news that the carcinogen benzene was found in multiple sunscreens, but that wasn’t the only major headline of the year. We revisit the 20 stories of 2021 that made the greatest impact.

With the complication rate of treatment declining and new devices now available, laser- and energy-based light treatment for acne and scarring continues to evolve.

Long underserved by a narrow armamentarium, patients with pigmentary disorders could soon see a new wave of oral and topical solutions to treat even the most challenging cases.

Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.

In this episode of DermView, Adelaide Hebert, MD, highlights both emollients and moisturizers. She also talks about bathing and how often a child should bathe if they have eczema.